Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I think this is worth watching

As far as the earnings that might be generated outside of MMP, don't be so quick to discount them, at least if we can believe what RG presents in that video. He states that these Fusion Centers are "a $100M build" and that PTSC's portion is just "millions of dollars within that" (stated at the 22:45 mark of the video). Based on that comment, if there are 70 of these centers in planning as we hear, and the Crossflo portion represents a minimum of $3M per center (in lines with millions of $100M overall), then thats $210M in potential revenue. Discount that by 60% to account for not all of the work going forward and for Crossflo not winning all of it, and you still have an $84M potential revenue source. Add in the Healthcare aspect of the technology, and there should be tons more potential from that side of things. In the slide presentation that accompanies RG's video, he cites the Fusion Center market as a $1.2 BILLION market opportunity for Crossflo, and that's before the Healthcare opportunities.


Obviously those are GIANT steps from where we are now, but HP is a good partner to have in this endeavor, IMO. And according to RG, there is NO COMPETITION in the component that Crossflo provides. So the POTENTIAL of big revenues is there. As always, we'll have to see where they go. This is all the more reason that RG needs to be forthright and transparent in disclosures about the companies activities, IMO, as that will only ADD to his credibility. When you take into account the questionable historical baggage he has to deal with, "dancing" around the disclosure issues detracts from that credibility in my opinion.

Share
New Message
Please login to post a reply